All insiders
TC
Turtle Cameron
CEOPrimarily SYRE
0% buying100% selling
Total Trades
40
0 buys · 40 sells
Total Bought
$0
Total Sold
$11.37M
Companies
1
Buy Win Rate
—
insufficient data
Avg Buy Return*
—
Active
Nov 3, 2025 → Oct 1, 2026
Trade Volume by Year
Buy Sell
Top Traded Sectors
Pharmaceutical Preparations40
Most-Traded Stocks
 SYRESpyre Therapeutics, Inc. | 40 | 0B / 40S | $11.37M |
Trade History
| Oct 1, 2026 | SYRE | SELL | 4,990 | $93.37 | $465.92K |
| Oct 1, 2026 | SYRE | SELL | 100 | $93.91 | $9.39K |
| Oct 1, 2026 | SYRE | SELL | 600 | $89.14 | $53.48K |
| Oct 1, 2026 | SYRE | SELL | 2,683 | $90.10 | $241.74K |
| Oct 1, 2026 | SYRE | SELL | 2,638 | $91.49 | $241.35K |
| Oct 1, 2026 | SYRE | SELL | 3,989 | $92.31 | $368.22K |
| Sep 1, 2026 | SYRE | SELL | 8,400 | $87.15 | $732.06K |
| Sep 1, 2026 | SYRE | SELL | 400 | $89.07 | $35.63K |
| Sep 1, 2026 | SYRE | SELL | 3,700 | $88.06 | $325.82K |
| Sep 1, 2026 | SYRE | SELL | 2,500 | $86.36 | $215.90K |
| Aug 3, 2026 | SYRE | SELL | 16 | $97.46 | $1.56K |
| Aug 3, 2026 | SYRE | SELL | 800 | $93.97 | $75.18K |
| Aug 3, 2026 | SYRE | SELL | 7,157 | $95.10 | $680.63K |
| Aug 3, 2026 | SYRE | SELL | 5,635 | $95.93 | $540.57K |
| Aug 3, 2026 | SYRE | SELL | 1,392 | $96.82 | $134.77K |
| Jul 1, 2026 | SYRE | SELL | 4,234 | $88.12 | $373.10K |
| Jul 1, 2026 | SYRE | SELL | 590 | $88.91 | $52.46K |
| Jul 1, 2026 | SYRE | SELL | 10,176 | $87.44 | $889.79K |
| Jun 1, 2026 | SYRE | SELL | 8,149 | $70.50 | $574.50K |
| Jun 1, 2026 | SYRE | SELL | 3,294 | $71.38 | $235.13K |
| Jun 1, 2026 | SYRE | SELL | 3,557 | $69.40 | $246.86K |
| May 1, 2026 | SYRE | SELL | 3,600 | $70.77 | $254.77K |
| May 1, 2026 | SYRE | SELL | 1,000 | $71.76 | $71.76K |
| May 1, 2026 | SYRE | SELL | 3,100 | $73.14 | $226.73K |
| May 1, 2026 | SYRE | SELL | 1,700 | $74.23 | $126.19K |
1–25 of 40
Page 1 of 2
*Return = current share price vs the insider’s purchase price (buys only). Not the insider’s realized return. Informational only — not investment advice.